Anti Itch Cream
NDC Package 51141-0054-2
Package Information
Anti Itch Cream is adults and children 12 years of age and over: apply to affected area not more than 3 to 4 times dailychildren under 12 years of age: ask a doctordo not use more often than directed. Marketed by Neopharm Co., Ltd., this product is identified by NDC 51141-0054 and is authorized under FDA application part336.
Identification & Billing
- RxCUI: 1087026 - diphenhydrAMINE HCl 2 % / zinc acetate 0.1 % Topical Cream
- RxCUI: 1087026 - diphenhydramine hydrochloride 20 MG/ML / zinc acetate 1 MG/ML Topical Cream
- RxCUI: 1087026 - diphenhydramine hydrochloride 2 % / zinc acetate 0.1 % Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 51141 - Neopharm Co., Ltd.
- 51141-0054 - Anti Itch Cream
- 51141-0054-2 - 1 TUBE in 1 BOX / 57 g in 1 TUBE
- 51141-0054 - Anti Itch Cream
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (51141-0054). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 51141-0054-2 identifies a specific commercial package of 1 tube in 1 box / 57 g in 1 tube of Anti Itch Cream, labeled by Neopharm Co., Ltd.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Neopharm Co., Ltd. on September 07, 2010. The current certification is valid through December 31, 2017.
How is this Neopharm Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 51141005402. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.